Peter Beddy1, Elizabeth M Genega2, Long Ngo3, Nicole Hindman4, Jesse Wei1, Andrea Bullock5, Rupal S Bhatt5, Michael B Atkins5, Ivan Pedrosa6. 1. Department of Radiology, St. James Hospital and Trinity College, Dublin, Ireland. 2. Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA. 3. Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA. 4. Department of Radiology, New York University Langone Medical Center, New York, NY. 5. Department of Medicine, Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, MA. 6. Department of Radiology, St. James Hospital and Trinity College, Dublin, Ireland. Electronic address: ivan.pedrosa@UTsouthwestern.edu.
Abstract
OBJECTIVE: The study objective was to correlate the magnetic resonance imaging (MRI) features of clear cell renal cell carcinoma (ccRCC) with the histopathologic features and disease progression. METHODS: Institutional review board approval for this retrospective study was obtained; patient consent was not required. The initial staging MRI scans of 75 patients with histologically confirmed ccRCC were retrospectively reviewed. The imaging was assessed by 2 radiologists for the presence of tumor necrosis, cystic degeneration, intracellular fat, hemorrhage, retroperitoneal collaterals, and renal vein thrombosis. Quantitative analysis for the MRI presence of intracellular lipid within tumors was performed. MRI findings were correlated with histopathologic findings of clear cell percentage, alveolar and tubular growth pattern, and disease progression. Statistical associations were evaluated with nonparametric univariable analyses and multivariable logistic regression models. RESULTS: Correlation between MRI and histopathologic features was performed in 75 patients, whereas follow-up data were available for progression analysis in 68 patients. The presence of tumor necrosis, retroperitoneal collaterals, and renal vein thrombosis on MRI was significantly associated with a low percentage of tumor cells with clear cytoplasm (P < .01) and metastatic disease at presentation or disease progression (P < .01). At multivariable analysis, necrosis remained the only feature statistically associated with disease progression (P = .03; adjusted odds ratio, 27.7; 95% confidence interval, 1.4-554.7 for reader 1 and P = .02; adjusted odds ratio, 29.3; 95% confidence interval, 1.7-520.8 for reader 2). CONCLUSIONS: Necrosis in ccRCC on MRI correlates with the histopathologic finding of lower percentage of tumor cells with clear cytoplasm and is a poor prognostic indicator irrespective of tumor size.
OBJECTIVE: The study objective was to correlate the magnetic resonance imaging (MRI) features of clear cell renal cell carcinoma (ccRCC) with the histopathologic features and disease progression. METHODS: Institutional review board approval for this retrospective study was obtained; patient consent was not required. The initial staging MRI scans of 75 patients with histologically confirmed ccRCC were retrospectively reviewed. The imaging was assessed by 2 radiologists for the presence of tumor necrosis, cystic degeneration, intracellular fat, hemorrhage, retroperitoneal collaterals, and renal vein thrombosis. Quantitative analysis for the MRI presence of intracellular lipid within tumors was performed. MRI findings were correlated with histopathologic findings of clear cell percentage, alveolar and tubular growth pattern, and disease progression. Statistical associations were evaluated with nonparametric univariable analyses and multivariable logistic regression models. RESULTS: Correlation between MRI and histopathologic features was performed in 75 patients, whereas follow-up data were available for progression analysis in 68 patients. The presence of tumor necrosis, retroperitoneal collaterals, and renal vein thrombosis on MRI was significantly associated with a low percentage of tumor cells with clear cytoplasm (P < .01) and metastatic disease at presentation or disease progression (P < .01). At multivariable analysis, necrosis remained the only feature statistically associated with disease progression (P = .03; adjusted odds ratio, 27.7; 95% confidence interval, 1.4-554.7 for reader 1 and P = .02; adjusted odds ratio, 29.3; 95% confidence interval, 1.7-520.8 for reader 2). CONCLUSIONS:Necrosis in ccRCC on MRI correlates with the histopathologic finding of lower percentage of tumor cells with clear cytoplasm and is a poor prognostic indicator irrespective of tumor size.
Authors: Nicole Hindman; Long Ngo; Elizabeth M Genega; Jonathan Melamed; Jesse Wei; Julia M Braza; Neil M Rofsky; Ivan Pedrosa Journal: Radiology Date: 2012-09-25 Impact factor: 11.105
Authors: Amnon Zisman; Allan J Pantuck; Jeffery Wieder; Debby H Chao; Fredrick Dorey; Jonathan W Said; Jean B deKernion; Robert A Figlin; Arie S Belldegrun Journal: J Clin Oncol Date: 2002-12-01 Impact factor: 44.544
Authors: Igor Frank; Michael L Blute; John C Cheville; Christine M Lohse; Amy L Weaver; Horst Zincke Journal: J Urol Date: 2002-12 Impact factor: 7.450
Authors: Nicola Schieda; Marc Dilauro; Bardia Moosavi; Taryn Hodgdon; Gregory O Cron; Matthew D F McInnes; Trevor A Flood Journal: Eur Radiol Date: 2015-10-20 Impact factor: 5.315
Authors: Stuart G Silverman; Ivan Pedrosa; James H Ellis; Nicole M Hindman; Nicola Schieda; Andrew D Smith; Erick M Remer; Atul B Shinagare; Nicole E Curci; Steven S Raman; Shane A Wells; Samuel D Kaffenberger; Zhen J Wang; Hersh Chandarana; Matthew S Davenport Journal: Radiology Date: 2019-06-18 Impact factor: 11.105
Authors: Nicola Schieda; Christian B van der Pol; Bardia Moosavi; Matthew D F McInnes; Kien T Mai; Trevor A Flood Journal: Eur Radiol Date: 2015-02-14 Impact factor: 5.315
Authors: Andreas M Hötker; Christoph A Karlo; Junting Zheng; Chaya S Moskowitz; Paul Russo; Hedvig Hricak; Oguz Akin Journal: AJR Am J Roentgenol Date: 2016-03-02 Impact factor: 3.959
Authors: Alexandra M Mowday; Ludwig J Dubois; Aleksandra M Kubiak; Jasmine V E Chan-Hyams; Christopher P Guise; Amir Ashoorzadeh; Philippe Lambin; David F Ackerley; Jeff B Smaill; Nigel P Minton; Jan Theys; Adam V Patterson Journal: Cancer Gene Ther Date: 2021-02-08 Impact factor: 5.987
Authors: Maryam Aghighi; Daniel Golovko; Celina Ansari; Neyssa M Marina; Laura Pisani; Lonnie Kurlander; Christopher Klenk; Srabani Bhaumik; Michael Wendland; Heike E Daldrup-Link Journal: PLoS One Date: 2015-11-16 Impact factor: 3.240